TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan adds generic Detrol, HIV/AIDS drugs

MYL $27.29 +$0.10

at close on THURSDAY

Daily Photo Galleries

Thursday, Nov. 29, 2012, 12:40 p.m.
 

Mylan Inc. said on Thursday that it had introduced a generic incontinence drug to the U.S. market and was selected by the South African government as a supplier of antiretroviral drugs.

Cecil-based Mylan has started selling Tolterodine Tartrate tablets, the generic version of Detrol, made by Pfizer Inc. Tolterodine Tartrate had U.S. sales of $61.5 million for the 12 months ended Sept. 30.

The company said the South African National Department of Health selected Mylan's Indian subsidiary to supply it with 31 percent of the 30 million units of HIV/AIDS drugs it will buy in a two-year period ending Dec. 31, 2014.

Mylan's share of the contract is valued at about $127.5 million.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Rams cruise as soccer launches section play
  2. BVA assistant enjoys ‘special’ part of game
  3. Bell Township museum delighted to receive WWI uniform of prominent native son
  4. 71-year-old among 2 charged in several Pittsburgh area burglaries
  5. Playoff losses motivate West Mifflin boys soccer
  6. Leader Times roundup: West Shamokin volleyball team wins 1st match in Class AA
  7. New Allegheny Valley Joint Sewage Authority manager welcomes challenge
  8. Four issues that the Steelers need to take care of in September
  9. Remember the Lusitania!
  10. New Kensington residents vent anger at council meeting
  11. Principals question role of test scores in new evaluation process
Subscribe today! Click here for our subscription offers.